Brith Leidvik

434 total citations
8 papers, 347 citations indexed

About

Brith Leidvik is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Brith Leidvik has authored 8 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Brith Leidvik's work include Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (2 papers) and Estrogen and related hormone effects (1 paper). Brith Leidvik is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (2 papers) and Estrogen and related hormone effects (1 paper). Brith Leidvik collaborates with scholars based in Sweden, United Kingdom and Germany. Brith Leidvik's co-authors include Charlotta Otter, Mats Hidestrand, Mikael Oscarson, Magnus Ingelman‐Sundberg, Eleni Aklillu, A. Edlund, Jan Taipalensuu, Hans Lennernäs, Marie E. Jönsson and Assar Bäckman and has published in prestigious journals such as Journal of Molecular Biology, Journal of Medicinal Chemistry and Archives of Biochemistry and Biophysics.

In The Last Decade

Brith Leidvik

8 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brith Leidvik Sweden 7 206 146 110 62 35 8 347
Sue Zhou United States 9 197 1.0× 117 0.8× 98 0.9× 13 0.2× 15 0.4× 9 345
Timothy Moeller United States 9 161 0.8× 134 0.9× 69 0.6× 58 0.9× 31 0.9× 10 356
M Umeno Japan 5 340 1.7× 164 1.1× 171 1.6× 63 1.0× 34 1.0× 6 470
Chunja Lee Canada 14 175 0.8× 191 1.3× 170 1.5× 53 0.9× 65 1.9× 22 494
Irene Persson Sweden 7 302 1.5× 132 0.9× 144 1.3× 65 1.0× 58 1.7× 8 466
Chika Nakamura Japan 14 237 1.2× 177 1.2× 244 2.2× 27 0.4× 33 0.9× 33 588
Katarina Stark Sweden 11 247 1.2× 151 1.0× 83 0.8× 27 0.4× 29 0.8× 12 421
Laura Lowe Furge United States 11 167 0.8× 352 2.4× 68 0.6× 35 0.6× 64 1.8× 26 560
M.J. Vilarem France 9 458 2.2× 212 1.5× 281 2.6× 158 2.5× 35 1.0× 14 742
Masami Miyamoto Japan 5 305 1.5× 272 1.9× 93 0.8× 42 0.7× 38 1.1× 6 476

Countries citing papers authored by Brith Leidvik

Since Specialization
Citations

This map shows the geographic impact of Brith Leidvik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brith Leidvik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brith Leidvik more than expected).

Fields of papers citing papers by Brith Leidvik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brith Leidvik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brith Leidvik. The network helps show where Brith Leidvik may publish in the future.

Co-authorship network of co-authors of Brith Leidvik

This figure shows the co-authorship network connecting the top 25 collaborators of Brith Leidvik. A scholar is included among the top collaborators of Brith Leidvik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brith Leidvik. Brith Leidvik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Gardelli, Cristina, Hiroki Wada, Asim K. Ray, et al.. (2018). Identification and Pharmacological Profile of an Indane Based Series of Ghrelin Receptor Full Agonists. Journal of Medicinal Chemistry. 61(14). 5974–5987. 12 indexed citations
2.
Aklillu, Eleni, Mikael Oscarson, Mats Hidestrand, et al.. (2002). Functional Analysis of Six Different Polymorphic CYP1B1 Enzyme Variants Found in an Ethiopian Population. Molecular Pharmacology. 61(3). 586–594. 110 indexed citations
3.
Aklillu, Eleni, Mikael Oscarson, Mats Hidestrand, et al.. (2002). Functional Analysis of Six Different Polymorphic CYP1B1 Enzyme Variants Found in an Ethiopian Population. Molecular Pharmacology. 61(3). 586–594. 6 indexed citations
4.
Engman, Helena, Hans Lennernäs, Jan Taipalensuu, et al.. (2001). CYP3A4, CYP3A5, and MDR1 in Human Small and Large Intestinal Cell Llines Suitable for Drug Transport Studies. Journal of Pharmaceutical Sciences. 90(11). 1736–1751. 54 indexed citations
5.
Jahn, Thomas P., Jens Dietrich, Birgitte Andersen, et al.. (2001). Large scale expression, purification and 2D crystallization of recombinant plant plasma membrane H+-ATPase. Journal of Molecular Biology. 309(2). 465–476. 21 indexed citations
6.
McLellan, Roman A., Mikael Oscarson, Mats Hidestrand, et al.. (2000). Characterization and Functional Analysis of Two Common Human Cytochrome P450 1B1 Variants. Archives of Biochemistry and Biophysics. 378(1). 175–181. 46 indexed citations
7.
Masimirembwa, Collen, Charlotta Otter, Mikael Berg, et al.. (1999). Heterologous Expression and Kinetic Characterization of Human Cytochromes P-450: Validation of a Pharmaceutical Tool for Drug Metabolism Research. Drug Metabolism and Disposition. 27(10). 1117–1122. 92 indexed citations
8.
Edlund, A., et al.. (1996). Structure of the human ϰ-casein gene. Gene. 174(1). 65–69. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026